A detailed history of Armstrong, Fleming & Moore, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Armstrong, Fleming & Moore, Inc holds 12,509 shares of PFE stock, worth $323,858. This represents 0.21% of its overall portfolio holdings.

Number of Shares
12,509
Previous 12,009 4.16%
Holding current value
$323,858
Previous $336 Million 7.74%
% of portfolio
0.21%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$27.7 - $31.39 $13,850 - $15,695
500 Added 4.16%
12,509 $362 Million
Q2 2024

Jul 22, 2024

SELL
$25.26 - $29.6 $3,182 - $3,729
-126 Reduced 1.04%
12,009 $336 Million
Q2 2023

Aug 16, 2023

BUY
$36.12 - $41.79 $438,316 - $507,121
12,135 New
12,135 $445 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Armstrong, Fleming & Moore, Inc Portfolio

Follow Armstrong, Fleming & Moore, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong, Fleming & Moore, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong, Fleming & Moore, Inc with notifications on news.